Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

MiRNA expression profiles of EVs from healthy control and MDS patients

ABSTRACT: miRNA expression profiles of EVs from healthy control and MDS patients

PROVIDER: PRJNA822396 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18568700.fastq.gz	Fastqsanger.gz
	SRR18568701.fastq.gz	Fastqsanger.gz
	SRR18568702.fastq.gz	Fastqsanger.gz
	SRR18568703.fastq.gz	Fastqsanger.gz
	SRR18568704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 97

Similar Datasets

miRNA expression profiles of EVs from healthy control and MDS patients

Project description:To investigated dysregulated miRNAs in human MDS patients, we performed miRNA-sequencing (miRNA-seq) of serum EVs from 38 MDS patients and 8 healthy subjects. The miRNA profile in EVs from MDS patients was distinctly clustered from that in healthy individuals. In addition, the miRNAs significantly upregulated in the MDS group target pathways linked to cell survival, proliferation, and MSC differentiation, indicating that they have remarkably similar properties to miRNAs in murine EVs from MDS cells. These results suggest that miRNAs play an essential role in the MSC impairment observed in MDS.

2023-01-01 | GSE199980 | GEO

miRNA expression profiles of EVs from control and MDS mice

Project description:To identify the mechanism by which miRNAs in EVs derived from MDS cells suppressed the osteolineage differentiation of MSCs and disrupted normal hematopoiesis, we comprehensively explored the miRNAs encapsulated in EVs by miRNA-array. Consistent with the heterogeneous nature of MDS, the hypoplastic Abcg2-MDS/AML model and the hyperplastic NHD13Tg model share few elevated miRNAs. However, it is noteworthy that the pathways targeted by each upregulated miRNA are mutually shared, such as the pathways associated with MSC differentiation and survival, including axon guidance and MAPK signaling. These results suggest that miRNAs play an essential role in the MSC impairment observed in MDS.

2022-10-01 | GSE199997 | GEO

miRNA expression profiles of EVs from control and MDS mice

Project description:miRNA expression profiles of EVs from control and MDS mice

| PRJNA822419 | ENA

EVs MSC miRNA-seq

Project description:EVs MSC miRNA-seq

| PRJNA745950 | ENA

miRNA expression data from HPC-EVs

Project description:miRNA expression data from HPC-EVs

| PRJNA1030338 | ENA

NanoString assays of miRNA in MCF7 and MCF10A cells and in extracellular vesicles (EVs) derived from these cells.

Project description:The goal of this study is to identify unique miRNA profiles of EVs from MCF7 and MCF10A cells that distinguish their cellular origin. 654 human mature miRNAs were analyzed in NanoString assays to identify miRNA with high abundance in MCF7 EVs and the greatest fold change for MCF7 EVs relative to MCF10A EVs.

2015-02-21 | E-GEOD-66165 | biostudies-arrayexpress

Expression data from bone marrow CD34+ cells of MDS patients and healthy controls

Project description:In order to gain insight into the molecular pathogenesis of the myelodysplastic syndromes (MDS), we performed global gene expression profiling and pathway analysis on the hematopoietic stem cells (HSC) of 183 MDS patients as compared with the HSC of 17 healthy controls. The most significantly deregulated pathways in MDS include interferon signaling, thrombopoietin signaling and the Wnt pathway. Among the most significantly deregulated gene pathways in early MDS are immunodeficiency, apoptosis and chemokine signaling, whereas advanced MDS is characterized by deregulation of DNA damage response and checkpoint pathways. We have identified distinct gene expression profiles and deregulated gene pathways in patients with del(5q), trisomy 8 or –7/del(7q). Patients with trisomy 8 are characterized by deregulation of pathways involved in the immune response, patients with –7/del(7q) by pathways involved in cell survival, whilst patients with del(5q) show deregulation of integrin signaling and cell cycle regulation pathways. This is the first study to determine deregulated gene pathways and ontology groups in the HSC of a large group of MDS patients. The deregulated pathways identified are likely to be critical to the MDS HSC phenotype and give new insights into the molecular pathogenesis of this disorder thereby providing new targets for therapeutic intervention.

2010-03-13 | GSE19429 | GEO

Expression profiling of purified hematopoietic stem cells from patients with MDS and healthy controls

Project description:Gene expression analysis on purified human long-term hematopoietic stem cells (LT-HSC; CD34+CD38-CD90+) and short-term HSC (ST-HSC; CD34+CD38-CD90-) derived from healthy control patients and patients with myelodysplastic syndrome (MDS)

2012-08-01 | GSE38955 | GEO

Next Generation Sequencing analysis to compare expression patterns of myeloid progenitors in healthy donors and MDS patients

Project description:Transcriptional changes occurring in the CMPs and GMPs of untreated "CMP pattern" and "GMP pattern" MDS patients were compared with the transcriptional profile of CMPs and GMPs from healthy donors

2022-01-02 | GSE178840 | GEO

miRNA profiles of EVs released from menstrual blood-derived stem cells

Project description:miRNA profiles of EVs released from menstrual blood-derived stem cells

| PRJNA926662 | ENA